Ellison Mark Jason Heath 4
4 · OPIANT PHARMACEUTICALS, INC. · Filed Jul 30, 2019
Insider Transaction Report
Form 4
Transactions
- Tax Payment
Common Stock
2019-07-29$12.26/sh−24,470$300,002→ 5,530 total(indirect: See Footnote (1)) - Exercise/Conversion
Common Stock
2019-07-29$10.00/sh+30,000$300,000→ 30,000 total(indirect: See Footnote (1)) - Exercise/Conversion
Common Stock
2019-07-29−30,000→ 0 total(indirect: See footnote (2))Exercise: $10.00From: 2014-08-02Exp: 2019-08-01→ Common Stock (30,000 underlying)
Footnotes (3)
- [F1]The shares are held by Phax Limited, of which the Reporting person serves as the Director.
- [F2]Represents shares theoretically withheld by the Issuer pertaining to the cashless net exercise of 30,000 option shares. No shares were actually disposed of by the Reporting person.
- [F3]All of the shares subject to this option are fully vested and exercisable as of the date hereof.